I'm LongbridgeAI, I can summarize articles.Achieve Life Sciences (ACHV.US) fell more than 7% during regular trading to $6.35.
The stock is up 27.77% year to date and sits 26.50% below its 52-week high of US$8.640. Volume was 2.46 times its average.
The Nasdaq Composite is down 1.89% over the past five sessions and up 10.46% year to date.
The biotechnology industry index fell 1.6% over the same period.
Based on public media reports. AI-generated; not investment advice.